Internal Medicine, Hematology & Oncology · Gadsden, AL
NPI
1376520254
Since 2005
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
3
Medicare group memberships
Hospitals
5
Hospital affiliations
355 S 2nd St
Gadsden, AL, 35901
Phone (256) 547-0536
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.7M
130,788 services
Medicare patients, 2024
446
Average age 75
Drug cost, 2024
$14.8M
3,699 prescriptions
Company payments, 2025
$1,309
From 22 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ashvini Sengar was code Q0138 (injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use)), 16,830 times for 22 patients. In total Ashvini Sengar billed 130,788 services in 167 codes, and Medicare paid $1.7M.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-06-15.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|
| Q0138 Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | Office | 16,830 | 22 | $0.26 | $4,450 |
| J9263 Injection, oxaliplatin, 0.5 mg | Office | 15,400 | 11 | $0.03 | $535 |
| J0897 Injection, denosumab, 1 mg | Office | 8,160 | 52 | $12.97 | $106K |
| J1453 Injection, fosaprepitant, 1 mg | Office | 7,050 | 16 | $0.05 | $346 |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 2,734 | 70 | $0.09 | $247 |
| J1568 Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg | Office | 2,270 | 11 | $10.26 | $23K |
| J0885 Injection, epoetin alfa, (for non-esrd use), 1000 units | Office | 1,240 | 16 | $0.11 | $140 |
| J2405 Injection, ondansetron hydrochloride, per 1 mg | Office | 1,140 | 38 | $0.07 | $83.94 |
| J2469 Injection, palonosetron hcl, 25 mcg | Office | 1,090 | 26 | $0.40 | $431 |
| 85025 Blood Count | Office | 806 | 205 | $7.60 | $6,123 |
| 96367 Intravenous Infusion, Hydration | Office | 603 | 66 | $20.22 | $12K |
| J9190 Injection, fluorouracil, 500 mg | Office | 497 | 12 | $2.22 | $1,102 |
| 96375 Injection Administration | Office | 458 | 83 | $10.92 | $5,002 |
| 36415 Venipuncture Blood Collection | Office | 363 | 124 | $8.65 | $3,140 |
| J1200 Injection, diphenhydramine hcl, up to 50 mg | Office | 345 | 86 | $0.65 | $225 |
By year: 2022 $1.4M for 121,411 services; 2023 $1.2M for 109,821 services; 2024 $1.7M for 130,788 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 806 | 205 | $7.60 | $6,123 |
| 36415 Venipuncture Blood Collection | 363 | 124 | $8.65 | $3,140 |
| 80053 Clinical Chemistry | 307 | 97 | $10.35 | $3,177 |
| 82728 Clinical Chemistry | 69 | 39 | $13.36 | $922 |
| 83550 Clinical Chemistry | 67 | 38 | $8.57 | $574 |
| 83540 Clinical Chemistry | 66 | 38 | $6.34 | $418 |
| 86300 Immunoassay | 58 | 24 | $20.39 | $1,183 |
| 82378 Clinical Chemistry | 29 | 14 | $18.58 | $539 |
| 82607 Clinical Chemistry | 27 | 20 | $14.78 | $399 |
| 82746 Clinical Chemistry | 26 | 20 | $14.41 | $375 |
Medicare prescription drug claims, 2024
In 2024, the drug Ashvini Sengar prescribed most often to Medicare patients was Prolia (Denosumab), with 188 prescriptions and refills. In total Ashvini Sengar wrote 3,699 Medicare prescriptions that cost $14.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Prolia Denosumab | 188 | 1,128 | 133 | $315K |
| Letrozole Generic | 183 | 312 | 52 | $3,260 |
| Procrit Epoetin Alfa | 152 | 152 | 59 | $258K |
| Palonosetron Hcl Generic | 137 | 138 | 48 | $11K |
| Fosaprepitant Dimeglumine Generic | 107 | 108 | 33 | $17K |
| Xgeva Denosumab | 98 | 118 | 22 | $307K |
| Neulasta Onpro Pegfilgrastim | 98 | 99 | 30 | $727K |
| Prednisone Generic | 97 | 100 | 27 | $497 |
| Xtandi Enzalutamide | 85 | 85 | 12 | $1.1M |
| Keytruda Pembrolizumab | 74 | 79 | Under 11 | $961K |
| Ondansetron Hcl Generic | 72 | 74 | 51 | $1,390 |
| Octagam Immun Globg(Igg)/Malt/Iga Ov50 | 70 | 84 | 13 | $561K |
| Mvasi Bevacizumab-Awwb | 68 | 68 | 15 | $455K |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 65 | 66 | 22 | $867 |
| Abiraterone Acetate Generic | 65 | 65 | Under 11 | $303K |
Brand drugs: - claims; generic drugs: 1,957 claims; opioid claims: 171.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Ashvini Sengar $1,309 ($1,309 in general payments such as food, travel and fees) from 22 companies. The largest payer was Novartis Pharmaceuticals Corporation with $301.
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation NVS | 11 | $301 |
| Array Biopharma Inc PFE | 5 | $115 |
| Celgene Corporation BMY | 5 | $106 |
| Gilead Sciences, Inc. GILD | 4 | $76.36 |
| Merck Sharp & Dohme LLC MRK | 4 | $76.06 |
| E.R. Squibb & Sons, L.L.C. BMY | 4 | $72.83 |
| AstraZeneca Pharmaceuticals LP AZN | 1 | $68.49 |
| Pfizer Inc. PFE | 4 | $68.44 |
| Abbvie Inc. ABBV | 3 | $61.47 |
| Janssen Biotech, Inc. JNJ | 3 | $60.43 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.